Core Laboratories CLB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Corporate And Other | -$513K-42.5% | -$450K-33.5% | -$370K+1.1% | -$409K-59.8% | -$360K+3.0% | |
| Operating Segment Production Enhancement | $176.02M+0.6% | $178.84M+0.6% | $175.31M-2.0% | $174.57M+0.6% | $174.99M+0.8% | |
| Operating Segment Reservoir Description | $348.72M+1.7% | $347.68M+0.4% | $342.19M-0.5% | $342.81M+0.7% | $342.81M+1.6% | |
| Other Operating Income Expense Net by Business | ||||||
| Corporate And Other | $1.68M— | $2.03M— | —— | —— | —— | |
| Operating Segment Production Enhancement | $954K+207% | $284K+152% | -$748K-1,430% | -$973K-4,040% | -$889K-353% | |
| Operating Segment Reservoir Description | $8.61M-14.7% | $6.05M-47.6% | $11.37M+89.4% | $10.29M+392% | $10.09M+15,077% | |
| Operating Income by Business | ||||||
| Corporate And Other | -$148K-116% | $490K+2.3% | $618K+29.3% | $727K+37.2% | $951K+108% | |
| Operating Segment Production Enhancement | $11.36M— | $12.06M— | —— | —— | —— | |
| Operating Segment Reservoir Description | $42.75M-8.9% | $43.94M-14.6% | $47.76M+1.4% | $47.67M+9.4% | $46.91M+3.2% | |
| Total Assets by Business | ||||||
| Corporate And Other | $483.45M0.0% | $488.71M+0.1% | $495.85M+2.0% | $493.22M+0.9% | $483.45M-2.3% | |
| Operating Segment Production Enhancement | $572.23M-7.0% | $580.39M-7.5% | $588.87M-7.9% | $600.65M-7.2% | $615.13M-5.6% | |
| Operating Segment Reservoir Description | $1.31B+3.0% | $1.29B+2.3% | $1.28B+1.8% | $1.28B+3.4% | $1.27B+3.2% | |
| Cost of Goods Sold by Business | ||||||
| Corporate And Other | $1.16M+289% | $924K+264% | -$10K+96.7% | -$431K+14.4% | -$613K+46.0% | |
| Operating Segment Production Enhancement | $146.26M-1.4% | $147.39M-3.0% | $148.4M-0.1% | $149.34M+2.1% | $148.35M+0.8% | |
| Operating Segment Reservoir Description | $272.78M+1.9% | $269.27M0.0% | $265.88M-0.1% | $267.27M+2.1% | $267.66M+3.6% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Corporate And Other | $257K-20.9% | $209K-30.1% | $215K— | $102K— | $325K— | |
| Operating Segment Production Enhancement | $1.38M-38.0% | $2.2M+67.1% | $2.29M+54.3% | $2.54M+95.8% | $2.23M+57.8% | |
| Operating Segment Reservoir Description | $14.27M+29.6% | $12.18M+6.7% | $12.81M+29.3% | $12.38M+18.1% | $11M+14.9% | |
| General And Administrative Expense by Business | ||||||
| Corporate And Other | $0— | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $15.91M+8.9% | $15.77M+10.8% | $15.44M+6.7% | $14.75M-1.6% | $14.62M-3.1% | |
| Operating Segment Reservoir Description | $30.59M+13.3% | $29.66M+16.2% | $28.44M+8.2% | $27.09M-0.4% | $27.01M+0.4% | |
| Foreign Currency Transaction Gain Loss Before Tax by Business | ||||||
| Corporate And Other | -$173K-468% | -$181K-291% | -$110K-289% | -$26K+54.8% | $47K+124% | |
| D&A by Business | ||||||
| Corporate And Other | $0— | $0— | $0+100% | $0+100% | $0+100% | |
| Operating Segment Production Enhancement | $4M-7.3% | $4.12M-4.1% | $4.22M-6.0% | $4.28M-4.5% | $4.32M-2.1% | |
| Operating Segment Reservoir Description | $10.7M+1.8% | $10.53M-1.2% | $10.43M-6.7% | $10.45M-7.3% | $10.51M-7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Core Laboratories break its business down?
- Core Laboratories (CLB) reports revenue by business across 3 parts — Corporate And Other, Operating Segment Production Enhancement and Operating Segment Reservoir Description. Each is extracted from the segment footnotes and tracked over time.
- Where does Core Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Core Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
